Development and In-Vitro Characterization of a Personalized, pH-Responsive Polypill for Dual-Drug Delivery via Multi-Material FDM 3D Printing

Clicks: 4
ID: 309128
2025
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #46 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
This study explores the development of a personalized polypill designed to deliver two drugs with distinct, pH-sensitive release profiles using multi-material 3D printing via fused deposition modeling (FDM). The aim was to engineer a single tablet capable of releasing each drug independently at its intended site within the gastrointestinal tract. To achieve this, two drug-loaded filaments were prepared through hot-melt extrusion (HME). One filament, intended for immediate release, incorporated paracetamol within a polyvinyl alcohol (PVA) matrix. The other, designed for enteric release, embedded mesalazine in Eudragit L100. These filaments were used to print a core-shell tablet, with the mesalazine-containing core fully enclosed by the paracetamol-based shell. The printed tablets were evaluated for their physical integrity, chemical composition, and drug release behavior. In vitro dissolution testing was conducted using a USP Apparatus II paddle system, simulating gastrointestinal conditions through a pH-shift protocol—starting with 0.1N hydrochloric acid for two hours, followed by a phosphate buffer at pH 7.4. Results showed that the extrusion process produced filaments with uniform drug distribution and excellent printability. The tablets demonstrated high dimensional accuracy and allowed for precise, customizable dosing. During dissolution, the outer shell released over 95% of paracetamol rapidly in the acidic phase, while the mesalazine core remained intact. Upon transitioning to the neutral pH environment, the enteric coating dissolved, enabling a complete and controlled release of mesalazine. Overall, the findings highlight the promise of multi-material FDM 3D printing in fabricating sophisticated, pH-responsive polypills. This approach offers a viable pathway for creating patient-specific combination therapies with tailored dosing and release kinetics, potentially transforming personalized medicine.
Reference Key
imported_1761926353_6904dcd1830eb Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Vrushali Kulkarni, Namdeo Jadhav*
Journal International Journal of Pharmaceutical Drug Design (IJPDD)
Year 2025
DOI
10.62896/ijpdd.2.9.02
URL
https://ijpdd.org/index.php/files/article/view/318
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.